Header Logo

Connection

SUSAN BLANEY to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Drug Therapy, Combination.
SUSAN BLANEY
Connection Strength
0.015
Drug Therapy, Combination
  1. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009 Feb; 52(2):169-76.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.